121 related articles for article (PubMed ID: 18406916)
1. Quality assurance/quality control issues for intraoperative planning and adaptive repeat planning of image-guided prostate implants.
Zaider M; Cohen G; Meli J; Rosenfeld AB
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S152-6. PubMed ID: 18406916
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
Zelefsky MJ; Yamada Y; Cohen GN; Sharma N; Shippy AM; Fridman D; Zaider M
Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
[TBL] [Abstract][Full Text] [Related]
3. Current brachytherapy quality assurance guidance: does it meet the challenges of emerging image-guided technologies?
Williamson JF
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S18-22. PubMed ID: 18406923
[TBL] [Abstract][Full Text] [Related]
4. Quality assurance issues for computed tomography-, ultrasound-, and magnetic resonance imaging-guided brachytherapy.
Cormack RA
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S136-41. PubMed ID: 18406913
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
6. Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion.
Tanaka O; Hayashi S; Matsuo M; Nakano M; Uno H; Ohtakara K; Miyoshi T; Deguchi T; Hoshi H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):614-8. PubMed ID: 17869675
[TBL] [Abstract][Full Text] [Related]
7. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
[TBL] [Abstract][Full Text] [Related]
8. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64.
Yu Y; Anderson LL; Li Z; Mellenberg DE; Nath R; Schell MC; Waterman FM; Wu A; Blasko JC
Med Phys; 1999 Oct; 26(10):2054-76. PubMed ID: 10535622
[TBL] [Abstract][Full Text] [Related]
9. Minimizing the number of implantation needles for prostate (125)I brachytherapy: an investigation of possibilities and implications.
Steggerda MJ; van der Poel HG; Moonen LM
Brachytherapy; 2010; 9(4):319-27. PubMed ID: 20691644
[TBL] [Abstract][Full Text] [Related]
10. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
Albertsen PC
J Urol; 2005 Nov; 174(5):1969-70. PubMed ID: 16217368
[No Abstract] [Full Text] [Related]
11. Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques.
Jacob D; Raben A; Sarkar A; Grimm J; Simpson L
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):820-7. PubMed ID: 18455325
[TBL] [Abstract][Full Text] [Related]
12. External beam radiotherapy boosts to reduce the impact caused by edema in prostate permanent seed implants.
Yue N; Mori J; Nath R; Heron DE; Huq MS
Phys Med Biol; 2006 May; 51(9):2267-77. PubMed ID: 16625041
[TBL] [Abstract][Full Text] [Related]
13. Effect of post-implant edema on prostate brachytherapy treatment margins.
Reed DR; Wallner K; Ford E; Mueller A; Merrick G; Maki J; Sutlief S; Butler W
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1469-73. PubMed ID: 16137839
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography-based dosimetry.
Westendorp H; Hoekstra CJ; van't Riet A; Minken AW; Immerzeel JJ
Brachytherapy; 2007; 6(4):231-7. PubMed ID: 17991620
[TBL] [Abstract][Full Text] [Related]
15. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.
Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D
Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608
[TBL] [Abstract][Full Text] [Related]
16. An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry.
Toye W; Das R; Kron T; Franich R; Johnston P; Duchesne G
Radiother Oncol; 2009 May; 91(2):243-8. PubMed ID: 18954914
[TBL] [Abstract][Full Text] [Related]
17. The value of Day 1 imaging following LDR prostate brachytherapy.
Nobes JP; Laing R; Langley S
Radiother Oncol; 2008 Feb; 86(2):288-9; author reply 289-90. PubMed ID: 17963906
[No Abstract] [Full Text] [Related]
18. In vivo dosimetry with a linear MOSFET array to evaluate the urethra dose during permanent implant brachytherapy using iodine-125.
Bloemen-van Gurp EJ; Haanstra BK; Murrer LH; van Gils FC; Dekker AL; Mijnheer BJ; Lambin P
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1266-72. PubMed ID: 19665317
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131 Cs and 125 I for prostate permanent implant brachytherapy.
Sahgal A; Jabbari S; Chen J; Pickett B; Roach M; Weinberg V; Hsu IC; Pouliot J
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):247-54. PubMed ID: 18722275
[TBL] [Abstract][Full Text] [Related]
20. Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy.
Kudchadker RJ; Pugh TJ; Swanson DA; Bruno TL; Bolukbasi Y; Frank SJ
Med Dosim; 2012; 37(4):387-90. PubMed ID: 22560295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
